Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-12-21

FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved Allergan's supplemental application for VIIBRYD (vilazodone hydrochloride). The action is related to updates to the drug's labeling under the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viibryd (vilazodone)

Snippet

SUPPL AP for VIIBRYD (VILAZODONE HYDROCHLORIDE)